Objectives: We investigated the facial skin microbiota of Japanese acne patients. Methods: Skin swab samples were obtained from 100 acne patients and 28 healthy controls to evaluate Propionibacterium and Staphylococcus spp. using a culture method. Malassezia spp. were evaluated using a nonculture method. Antibiotic resistance of Propionibacterium spp. was also examined. Results: Acne patients and controls did not show significant differences in Propionibacterium and Staphylococcus spp. populations. However, the number of Malassezia globosa from patients was greater than that from controls. Moreover, the number of Propionibacterium spp. from patients carrying antibiotic-resistant strains was significantly greater than that from patients not carrying them. Conclusions: The present study characterized the facial skin microbiota of Japanese acne patients, suggesting a correlation between acne and quantitative differences in Malassezia microbiota. It was also found that the antibiotic resistance of Propionibacterium spp. may affect its abundance in the skin.

Keywords:
Cutaneous microbiota, Acne vulgaris, Propionibacterium, Staphylococcus, Malassezia
1.
Dekio I: Microorganisms and atopic dermatitis; in Gordillo JE (ed): Atopic Dermatitis - Disease Etiology and Clinical Management. Rijeka, InTech, 2012, pp 107-123.
2.
Harper JC, Thiboutot DM: Pathogenesis of acne: recent research advances. Adv Dermatol 2003;19:1-10.
3.
Kang S, Kim H: The isolation of Malassezia yeasts in the comedones of acne vulgaris. Korean J Med Mycol 1999;4:33-39.
4.
Till AE, Goulden V, Cunliffe WJ, Holland KT: The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ. Br J Dermatol 2000;142:885-892.
5.
Youn N, Cha S, Park S: Malassezia yeasts in acne vulgaris. Korean J Med Mycol 2002;40:1453-1460.
6.
Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, Tosti G, Katsambas A, Galvan Perez Del Pulgar JI, Rollman O, Torok L, Eady EA, Cove JH: Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003;148:467-478.
7.
Hayashi N, Akamatsu H, Kawashima M: Establishment of grading criteria for acne severity. J Dermatol 2008;35:255-260.
8.
Keyworth N, Millar MR, Holland KT: Swab-wash method for quantitation of cutaneous microflora. J Clin Microbiol 1990;28:941-943.
9.
Numata S, Akamatsu H, Akaza N, Sasaki Y, Takeoka S, Mizutani H, Nakata S, Matsunaga K: Quantitative effect of face washing on cutaneous resident microbiota in female subjects who wear make-up. J Dermatol 2012;39:1100-1101.
10.
Akaza N, Akamatsu H, Sasaki Y, Takeoka S, Kishi M, Mizutani H, Sano A, Hirokawa K, Nakata S, Matsunaga K: Cutaneous Malassezia microbiota in atopic dermatitis patients differ by gender and body part. Dermatology 2010;221:253-260.
11.
Akaza N, Akamatsu H, Sasaki Y, Kishi M, Mizutani H, Sano A, Hirokawa K, Nakata S, Nishijima S, Matsunaga K: Malassezia folliculitis is caused by cutaneous resident Malassezia species. Med Mycol 2009;47:618-624.
12.
Dumont-Wallon G, Moyse D, Blouin E, Dreno B: Bacterial resistance in French acne patients. Int J Dermatol 2010;49:283-288.
13.
McGinley KJ, Webster GF, Leyden JJ: Regional variations of cutaneous propionibacteria. Appl Environ Microbiol 1978;35:62-66.
14.
Eishi Y, Suga M, Ishige I, Kobayashi D, Yamada T, Takemura T, Takizawa T, Koike M, Kudoh S, Costabel U, Guzman J, Rizzato G, Gambacorta M, du Bois R, Nicholson AG, Sharma OP, Ando M: Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 2002;40:198-204.
15.
Leyden JJ, McGinley KJ, Mills OH, Kligman AM: Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975;65:382-384.
16.
Miura Y, Ishige I, Soejima N, Suzuki Y, Uchida K, Kawana S, Eishi Y: Quantitative PCR of Propionibacterium acnes DNA in samples aspirated from sebaceous follicles on the normal skin of subjects with or without acne. J Med Dent Sci 2010;57:65-74.
17.
Burkhart CG, Burkhart CN, Lehmann PF: Acne: a review of immunologic and microbiologic factors. Postgrad Med J 1999;75:328-331.
18.
Luk NM, Hui M, Lee HC, Fu LH, Liu ZH, Lam LY, Eastel M, Chan YK, Tang LS, Cheng TS, Siu FY, Ng SC, Lai YK, Ho KM: Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong. J Eur Acad Dermatol Venereol 2013;27:31-36.
19.
Song M, Seo SH, Ko HC, Oh CK, Kwon KS, Chang CL, Kim MB: Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea. J Dermatol 2011;38:667-673.
20.
Kurokawa I, Nishijima S, Kawabata S: Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris. Eur J Dermatol 1999;9:25-28.
21.
Ishida N, Nakaminami H, Noguchi N, Kurokawa I, Nishijima S, Sasatsu M: Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris. Microbiol Immunol 2008;52:621-624.
22.
Nakase K, Nakaminami H, Noguchi N, Nishijima S, Sasatsu M: First report of high levels of clindamycin-resistant Propionibacterium acnes carrying erm(X) in Japanese patients with acne vulgaris. J Dermatol 2012;39:794-796.
23.
Bek-Thomsen M, Lomholt HB, Kilian M: Acne is not associated with yet-uncultured bacteria. J Clin Microbiol 2008;46:3355-3360.
24.
Kim GK: Seborrheic dermatitis and Malassezia species: how are they related? J Clin Aesthet Dermatol 2009;2:14-17.
25.
Youn SW, Park ES, Lee DH, Huh CH, Park KC: Does facial sebum excretion really affect the development of acne? Br J Dermatol 2005;153:919-924.
26.
Akaza N, Akamatsu H, Sasaki Y, Takeoka S, Kishi M, Mizutani H, Sano A, Hirokawa K, Nakata S, Matsunaga K: Cutaneous Malassezia microbiota of healthy subjects differ by sex, body part and season. J Dermatol 2010;37:786-792.
27.
Song YC, Hahn HJ, Kim JY, Ko JH, Lee YW, Choe YB, Ahn KJ: Epidemiologic study of Malassezia yeasts in acne patients by analysis of 26S rDNA PCR-RFLP. Ann Dermatol 2011;23:321-328.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.